Shared on04 Sep 25
As neither the net profit margin nor the discount rate have materially changed, fundamental valuation drivers remain stable and, as a result, the consensus analyst price target for Valmet Oyj is unchanged at €29.31. What's in the News Valmet will deliver a complete IntelliTissue 1600 tissue machine and related systems to PT Suparma Tbk's Surabaya mill, adding 26,500 annual tons of production capacity, with start-up planned for 2026.
Shared on23 Apr 25Fair value Decreased 4.64%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on17 Apr 25Fair value Decreased 1.74%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on09 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on02 Apr 25Fair value Decreased 1.39%
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on26 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on19 Mar 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on12 Mar 25Fair value Increased 5.15%
AnalystConsensusTarget has increased revenue growth from 3.4% to 4.1%.